Minimum apparent diffusion coefficients in the evaluation of brain tumors
- PMID: 16129247
- DOI: 10.1016/j.ejrad.2005.02.004
Minimum apparent diffusion coefficients in the evaluation of brain tumors
Abstract
Objective: To determine whether diffusion-weighted imaging by using minimum apparent diffusion coefficient (ADC(min)) values could differentiate various brain tumors including gliomas, metastases, and lymphomas.
Materials and methods: We examined 65 patients with histologically or clinically diagnosed brain tumors (12 low-grade gliomas, 31 high-grade gliomas, 14 metastatic tumors, and 8 lymphomas) using a 1.5 T MR unit. On diffusion-weighted imaging, the ADC(min) values were measured within the tumors and mean values were evaluated regarding statistical differences between groups.
Results: The ADC(min) values of low-grade gliomas (1.09+/-0.20 x 10(-3)mm(2)/s) were significantly higher (p<.001) than those of other tumors. There were no statistical significant differences between glioblastomas (0.70+/-0.16 mm(2)/s), anaplastic astrocytomas (0.77+/-0.21 mm(2)/s), metastases (0.78+/-0.21 mm(2)/s), and lymphomas. But, lymphomas had lower mean ADC(min) values (0.54+/-0.10mm(2)/s) than high-grade gliomas and metastases.
Conclusion: The ADC measurements may help to differentiate low-grade gliomas from high-grade gliomas, metastases, and lymphomas. Although there is no statistical difference, lymphomas seem to have marked restriction in diffusion coefficients.
Similar articles
-
Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema.Acta Radiol. 2009 Jul;50(6):682-9. doi: 10.1080/02841850902933123. Acta Radiol. 2009. PMID: 19449234
-
Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors.Eur J Radiol. 2006 Jun;58(3):394-403. doi: 10.1016/j.ejrad.2005.12.032. Epub 2006 Mar 9. Eur J Radiol. 2006. PMID: 16527438 Clinical Trial.
-
[Diffusion-weighted MRI in the differentiation of brain abscesses and necrotic tumors].Tani Girisim Radyol. 2004 Jun;10(2):110-8. Tani Girisim Radyol. 2004. PMID: 15236124 Turkish.
-
Magnetic resonance (MR) differential diagnosis of breast tumors using apparent diffusion coefficient (ADC) on 1.5-T.J Magn Reson Imaging. 2009 Aug;30(2):249-55. doi: 10.1002/jmri.21854. J Magn Reson Imaging. 2009. PMID: 19629992 Review.
-
Diffusion tensor and perfusion imaging of brain tumors in high-field MR imaging.Neuroimaging Clin N Am. 2012 May;22(2):123-34, ix. doi: 10.1016/j.nic.2012.02.001. Epub 2012 Mar 12. Neuroimaging Clin N Am. 2012. PMID: 22548924 Review.
Cited by
-
Diffusion-weighted MR imaging derived apparent diffusion coefficient is predictive of clinical outcome in primary central nervous system lymphoma.AJNR Am J Neuroradiol. 2010 Jan;31(1):60-6. doi: 10.3174/ajnr.A1750. Epub 2009 Sep 3. AJNR Am J Neuroradiol. 2010. PMID: 19729544 Free PMC article.
-
Brain Tumor Characterization Using Multibiometric Evaluation of MRI.Tomography. 2018 Mar;4(1):14-25. doi: 10.18383/j.tom.2017.00020. Tomography. 2018. PMID: 29675474 Free PMC article.
-
Pitfalls in the neuroimaging of glioblastoma in the era of antiangiogenic and immuno/targeted therapy - detecting illusive disease, defining response.Front Neurol. 2015 Feb 23;6:33. doi: 10.3389/fneur.2015.00033. eCollection 2015. Front Neurol. 2015. PMID: 25755649 Free PMC article. Review.
-
Predicting Genotype and Survival in Glioma Using Standard Clinical MR Imaging Apparent Diffusion Coefficient Images: A Pilot Study from The Cancer Genome Atlas.AJNR Am J Neuroradiol. 2018 Oct;39(10):1814-1820. doi: 10.3174/ajnr.A5794. Epub 2018 Sep 6. AJNR Am J Neuroradiol. 2018. PMID: 30190259 Free PMC article.
-
MR perfusion and diffusion imaging in the follow-up of recurrent glioblastoma treated with dendritic cell immunotherapy: a pilot study.Neuroradiology. 2011 Oct;53(10):721-31. doi: 10.1007/s00234-010-0802-6. Epub 2010 Nov 25. Neuroradiology. 2011. PMID: 21107549
MeSH terms
LinkOut - more resources
Full Text Sources
Medical